Discuss MannKind Corp.
MannKind Corp.
WKN: A2DMZL / Symbol: MNKD / Name: MannKind / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
2,31 €
3,61 %
MannKind (MNKD) had its price target lowered by Wedbush from $10.00 to $8.00. They now have an "outperform" rating on the stock.
Ratings data for MNKD provided by MarketBeat
MannKind (MNKD) was given a new $8.00 price target by Mizuho. They now have an "outperform" rating on the stock.
Ratings data for MNKD provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Pacific Biosciences of California Inc. diskutieren